- Home
- Labeler Index
- Sagent Pharmaceuticals
- 25021-223
- NDC Crossover: 25021-223 Cytarabine
NDC Crossover 25021-223 Cytarabine
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Cytarabine
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 25021-223 – Cytarabine, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Cytarabine
- OR Generic name: Cytarabine
- AND the same Administration Route: intrathecal; intravenous; subcutaneous
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
61703-155 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Hospira, Inc. | Human Prescription Drug |
61703-319 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Hospira, Inc. | Human Prescription Drug |
63323-120 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
68083-337 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Gland Pharma Limited | Human Prescription Drug |
71288-109 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |